Zydus Lifesciences zooms despite reporting 41% fall in Q4 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Zydus Lifesciences is currently trading at Rs. 365.60, up by 8.45 points or 2.37% from its previous closing of Rs. 357.15 on the BSE.
The scrip opened at Rs. 372.00 and has touched a high and low of Rs. 372.00 and Rs. 357.65 respectively. So far 149864 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 668.85 on 11-Jun-2021 and a 52 week low of Rs. 319.40 on 11-May-2022.
Last one week high and low of the scrip stood at Rs. 372.00 and Rs. 334.85 respectively. The current market cap of the company is Rs. 37110.67 crore.
The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 15.44% and 9.69% respectively.
Zydus Lifesciences has reported a fall of 46.87% in its net profit at Rs 246.90 crore for the quarter ended March 31, 2022 as compared to Rs 464.70 crore for the same quarter in the previous year. However, total income of the company increased by 4.07% at Rs 2,073 crore for Q4FY22 as compared Rs 1,991.90 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 41.47% in its net profit at Rs 397.40 crore for the quarter ended March 31, 2022 as compared to Rs 679 crore for the same quarter in the previous year. However, total income of the company increased by 8.32% at Rs 3,942.90 crore for Q4FY22 as compared Rs 3,639.90 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a fall of 41.88% in its net profit at Rs 857.90 crore as compared to Rs 1,476.20 crore for the previous year. However, total income of the company increased by 3.70% at Rs 8,160.60 crore for year under review as compared to Rs 7,869.30 crore for year ended March 31, 2021.
For the year ended March 31, 2022, on the consolidated basis, the company has reported 2-fold jump in its net profit at Rs 4,487.30 crore as compared to Rs 2,133.60 crore for the previous year. Total income of the company increased by 7.20% at Rs 15,489.90 crore for year under review as compared to Rs 14,449.10 crore for year ended March 31, 2021.
